title: Efficacy and safety of a single dose therapy of a 500 mg ciprofloxacin tablet in chancroid patients.
abstract: A single dose therapy of 500 mg ciprofloxacin was sufficient to cure 15 of 18 chancroid patients within six days and the remaining three within 7, 11 and 20 days respectively. The drug was well tolerated, and no serious side effects were observed. The MICs of ciprofloxacin for the isolated Haemophilus ducreyi strains ranged from 0.0015 to 0.02 mg/l (mean 0.01 mg/l). It may therefore be concluded from our study that the oral administration of ciprofloxacin to chancroid patients with or without buboes is highly effective and free from side effects.
authors.affiliation: Department of Communicable Disease Control, Ministry of Public Health, Bangkok, Thailand.
authors.forename: A
authors.initials: A
authors.lastname: Traisupa
authors.forename: C
authors.initials: C
authors.lastname: Wongba
authors.forename: P
authors.initials: P
authors.lastname: Tesavibul
mesh_terms: D000284:Administration, Oral; D000328:Adult; D002602:Chancroid / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000008:administration & dosage* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D013785:Thailand
chemical_list: D002939:Ciprofloxacin